Overview

Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to assess potential different properties of telmisartan, which due to its Vd, should result in stronger "beneficial" effects of AT1 blockade in tissues (e.g. aldosterone suppression and renin increase) plus stronger AT2 stimulation compared to candesartan
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Candesartan
Candesartan cilexetil
Telmisartan